StockData
Zeo ScientifiX, Inc. logo

Zeo ScientifiX, Inc. (ZEOX) stock

ZEOXOTCBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Financials through Q2 FY2026, quarter ended Apr 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.91+0.00 (+0.15%)

Close on Oct 19, 2026Market cap $7.08MP/E –Yield –

Zeo ScientifiX r&d expenses

Research and development expenses are spending on new products and technology.

Zeo ScientifiX's R&D Expenses for the twelve months ending Oct 31, 2022 was $791.30K. For fiscal 2025 it was $100.00K, down 39.0% from the year before. The highest annual figure on record is $1.12M in fiscal 2021.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Oct 31, 2025$100.00K-39.0%
FY2024Oct 31, 2024$164.00K-82.2%
FY2023Oct 31, 2023$922.70K+16.6%
FY2022Oct 31, 2022$791.30K-29.4%
FY2021Oct 31, 2021$1.12M+379.6%
FY2020Oct 31, 2020$233.53K+325.7%
FY2019Oct 31, 2019$54.86K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ1 2026Apr 30, 2026$31.00K+520.0%
Q1 FY2026CQ4 2025Jan 31, 2026$19.00K-29.6%
Q2 FY2025CQ1 2025Apr 30, 2025$42.00K-87.5%
Q1 FY2025CQ4 2024Jan 31, 2025$6.00K-95.3%
Q2 FY2024CQ1 2024Apr 30, 2024$5.00K-95.5%
Q1 FY2024CQ4 2023Jan 31, 2024$27.00K-90.2%
Q3 FY2023CQ2 2023Jul 31, 2023$335.00K+21.2%
Q4 FY2022CQ3 2022Oct 31, 2022$126.80K-45.6%
Q3 FY2022CQ2 2022Jul 31, 2022$111.60K+14.2%
Q2 FY2022CQ1 2022Apr 30, 2022$276.60K+822.0%
Q1 FY2022CQ4 2021Jan 31, 2022$276.30K+722.3%
Q3 FY2021CQ2 2021Jul 31, 2021$233.00K+223.6%
Q4 FY2020CQ3 2020Oct 31, 2020$97.73K–
Q3 FY2020CQ2 2020Jul 31, 2020$30.00K–
Q2 FY2020CQ1 2020Apr 30, 2020$33.60K–
Q1 FY2020CQ4 2019Jan 31, 2020$72.00K–

More Zeo ScientifiX figures

See a number that looks wrong?